As cystic fibrosis causes excessive mucus production, respiratory infections are quite common among patients. The NHS UK website has…
Articles by Patrícia Silva, PhD
The Italian health insurance system has agreed to cover cystic fibrosis patients’ use of Vertex Pharmaceuticals‘ Orkambi (lumacaftor/ivacaftor). Those eligible for…
A first-grader with cystic fibrosis (CF), Conor Fink, inspired a close family friend to hop on his bicycle and spend…
Books that deal with a disease that’s affecting you or your loved ones can be sometimes hard to read, but…
Anthera Pharmaceuticals has received news that could help it accelerate patient enrollment in a Phase 3 clinical trial of Sollpura (liprotamase) as…
Synspira is planning to start a first, or Phase 1, clinical test of SNSP113, its therapeutic candidate for the treatment of…
Celtaxsys announced it has completed enrollment of its Phase 2b clinical trial evaluating the company’s lead anti-inflammatory candidate, oral acebilustat, in…
Children with cystic fibrosis (CF) used the Spiro PD device by themselves to measure their lung function and take their breathing medication at…
The first of a series of young-adult fantasy books from Michael Seidelman features a teenage girl with cystic fibrosis (CF).
The first patient has been dosed in a Phase 2 clinical trial evaluating RPL554 as a treatment for cystic…